In recognition of Earth Day 2025, which falls on April 22, members of the eye care industry shared updates on their efforts ...

A virtual reality intervention administered during chemotherapy infusion yielded statistically significant reductions in ...

The FDA issued a complete response letter for a supplemental biologics license application, in which it did not approve ...

Hazelnut oral immunotherapy was safe and effective, but cross-desensitization for patients who also had walnut and cashew ...

Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...

Among adults with thyroid cancer, those with hypoparathyroidism after a thyroidectomy may have increased risk for several ...

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance ...

Children with inflammatory skin diseases are at an increased risk for sleep and psychological disorders, prompting clinicians ...

Socioeconomic factors likely contribute to racial and ethnic disparities in health care utilization among patients with ...

Let us temper our criticism with kindness. None of us comes fully equipped.”– Carl Sagan, The Demon-Haunted WorldThis month’s ...

In this expert perspective, Manjot K. Gill, MD, discusses faricimab for the management of retinal vein occlusion.

In this expert perspective, Manjot K. Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion.